Michael  Sardano net worth and biography

Michael Sardano Biography and Net Worth

President & General Counsel of Sensus Healthcare

Michael Sardano has served in many capacities at Sensus Healthcare, Inc. since 2013. Michael works on a range of issues for Sensus, including, State and Federal Regulatory Matters, Government Affairs, and SEC Compliance. Prior to joining Sensus, Michael served on the United States Senate Rules & Administration Committee working on campaign finance reform and 501(c)(4) “SuperPAC” regulations during the 2012 Presidential Election. A licensed attorney in the State of Florida, Michael graduated from Bentley University in 2010 with a Bachelor of Science in Management & Finance and graduated from New England School of Law in 2013 receiving his Juris Doctor.

What is Michael Sardano's net worth?

The estimated net worth of Michael Sardano is at least $360.68 thousand as of November 18th, 2025. Mr. Sardano owns 118,839 shares of Sensus Healthcare stock worth more than $360,676 as of September 24th. This net worth approximation does not reflect any other investments that Mr. Sardano may own. Learn More about Michael Sardano's net worth.

How do I contact Michael Sardano?

The corporate mailing address for Mr. Sardano and other Sensus Healthcare executives is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. Sensus Healthcare can also be reached via phone at (561) 922-5808 and via email at [email protected]. Learn More on Michael Sardano's contact information.

Has Michael Sardano been buying or selling shares of Sensus Healthcare?

Michael Sardano has not been actively trading shares of Sensus Healthcare over the course of the past ninety days. Most recently, on Tuesday, November 18th, Michael Sardano bought 1,000 shares of Sensus Healthcare stock. The stock was acquired at an average cost of $3.80 per share, with a total value of $3,800.00. Following the completion of the transaction, the general counsel now directly owns 118,839 shares of the company's stock, valued at $451,588.20. Learn More on Michael Sardano's trading history.

Who are Sensus Healthcare's active insiders?

Sensus Healthcare's insider roster includes Stephen Cohen (EVP), Joseph Sardano (CEO), and Michael Sardano (President & General Counsel). Learn More on Sensus Healthcare's active insiders.

Are insiders buying or selling shares of Sensus Healthcare?

In the last twelve months, Sensus Healthcare insiders bought shares 12 times. They purchased a total of 160,171 shares worth more than $565,414.51. The most recent insider tranaction occured on August, 31st when Director Eric Sachetta bought 27,304 shares worth more than $96,656.16. Insiders at Sensus Healthcare own 10.2% of the company. Learn More about insider trades at Sensus Healthcare.

Information on this page was last updated on 8/31/2026.

Michael Sardano Insider Trading History at Sensus Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2025Buy1,000$3.80$3,800.00118,839View SEC Filing Icon  
11/11/2025Buy1,000$4.26$4,260.00117,839View SEC Filing Icon  
8/13/2025Buy1,000$3.37$3,370.00116,839View SEC Filing Icon  
8/28/2023Buy1,000$2.99$2,990.0058,774View SEC Filing Icon  
8/8/2023Buy1,000$3.78$3,780.0057,774View SEC Filing Icon  
5/8/2023Buy1,000$3.00$3,000.0056,774View SEC Filing Icon  
9/13/2022Sell5,000$14.13$70,650.0049,519View SEC Filing Icon  
See Full Table

Michael Sardano Buying and Selling Activity at Sensus Healthcare

This chart shows Michael Sardano's buying and selling at Sensus Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sensus Healthcare Company Overview

Sensus Healthcare logo
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $3.01
Low: $3.01
High: $3.09

50 Day Range

MA: $3.11
Low: $2.85
High: $3.54

2 Week Range

Now: $3.01
Low: $2.66
High: $5.49

Volume

7,166 shs

Average Volume

61,673 shs

Market Capitalization

$49.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13